Evidence map›Paper›PMID 38890732›Full record

ArticleCardiovascular diabetology2024

Acute-to-chronic glycemic ratio as an outcome predictor in ischemic stroke in patients with and without diabetes mellitus.

Elisenda Climent, Ana Rodriguez-Campello, Joan Jiménez-Balado, Mercè Fernández-Miró, Jordi Jiménez-Conde, Gemma Llauradó, Ángel Ois, Juana A Flores, Elisa Cuadrado-Godia, Eva Giralt Steinhauer and 2 more

Abstract read
In one paragraph

Article in Cardiovascular diabetology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elisenda Climent *Endocrinology and Nutrition Department, Hospital del Mar, Barcelona, Spain.
Ana Rodriguez-Campello *IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Joan Jiménez-BaladoIMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Mercè Fernández-MiróEndocrinology and Nutrition Department, Hospital del Mar, Barcelona, Spain.
Jordi Jiménez-CondeIMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Gemma LlauradóEndocrinology and Nutrition Department, Hospital del Mar, Barcelona, Spain.
Ángel OisIMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Juana A FloresEndocrinology and Nutrition Department, Hospital del Mar, Barcelona, Spain.
Elisa Cuadrado-GodiaIMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Eva Giralt SteinhauerIMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Juan J ChillarónEndocrinology and Nutrition Department, Hospital del Mar, Barcelona, Spain. jchillaron@psmar.cat.
Neurovascular Research Group (NEUVAS)

Funding

Instituto de Salud Carlos III. Fondos FEDER, RICORS-ICTUS RD21/0006/0021 and P19/00011
6 · The paper itself

Abstract

objectiveElevated plasma glucose levels are common in patients suffering acute ischemic stroke (AIS), and acute hyperglycemia has been defined as an independent determinant of adverse outcomes. The impact of acute-to-chronic glycemic ratio (ACR) has been analyzed in other diseases, but its impact on AIS prognosis remains unclear. The main aim of this study was to assess whether the ACR was associated with a 3-month poor prognosis in patients with AIS. RESEARCH, DESIGN AND

methodsRetrospective analysis of patients admitted for AIS in Hospital del Mar, Barcelona. To estimate the chronic glucose levels (CGL) we used the formula eCGL= [28.7xHbA1c (%)]-46.7. The ACR (glycemic at admission / eCGL) was calculated for all subjects. Tertile 1 was defined as: 0.28-0.92, tertile 2: 0.92-1.13 and tertile 3: > 1.13. Poor prognosis at 3 months after stroke was defined as mRS score 3-6.

results2.774 subjects with AIS diagnosis were included. Age, presence of diabetes, previous disability (mRS), initial severity (NIHSS) and revascularization therapy were associated with poor prognosis (p values < 0.05). For each 0.1 increase in ACR, there was a 7% increase in the risk of presenting a poor outcome. The 3rd ACR tertile was independently associated with a poor prognosis and mortality. In the ROC curves, adding the ACR variable to the classical clinical model did not increase the prediction of AIS prognosis (0.786 vs. 0.781).

conclusionsACR was positively associated with a poor prognosis and mortality at 3-months follow-up after AIS. Subjects included in the 3rd ACR tertile presented a higher risk of poor prognosis and mortality. Baseline glucose or ACR did not add predictive value in comparison to only using classical clinical variables.

Indexed as

BiomarkersBlood GlucoseDiabetes MellitusIschemic StrokePredictive Value of TestsAgedAged, 80 and overDisability EvaluationFemaleGlycated HemoglobinHumansHyperglycemiaMaleMiddle AgedPrognosisRetrospective StudiesBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanAcute-to-chronic glycemic ratioDiabetesHyperglycemiaIschemic strokeMortality, outcome

Identifiers

PMID38890732
PMCPMC11186093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.